Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Other Expenses (Tables)

v3.22.0.1
Other Expenses (Tables)
12 Months Ended
Dec. 31, 2021
Analysis of income and expense [abstract]  
Other expenses and adjustments
For the years ended December 31, 2021 2020 2019
Included in research and development expenses:
Employee compensation and benefits $ 4,645,264  $ 3,775,263  $ 3,096,231 
Share-based compensation 2,086,608  1,043,373  561,420 
Included in operating expenses
Depreciation - property and equipment $ 130,243  $ 88,957  $ 122,982 
Depreciation - right-of-use assets 321,822  357,230  362,592 
Employee compensation and benefits 2,542,210  2,635,170  2,555,274 
Share-based compensation 1,739,293  1,515,601  908,733 
Transaction cost, warrant derivative   —  233,143